InSphero Expands 3D Cell Model Leadership with Acquisition of DOPPL SA and Sun Bioscience Gri3D® Technology

Schlieren, Switzerland -- InSphero AG, the global market leader in 3D cell-based assays and organ-on-chip systems signed the definitive agreement to acquire DOPPL SA, a Lausanne-based innovator in the organoid space, including the Sun Bioscience Gri3D® technology. The acquisition strengthens InSphero’s position as the most comprehensive provider of advanced 3D in vitro models, combining scalable spheroid and organoid technologies with integrated assay [...]

Oxford Nanopore announces senior leadership changes

Oxford Nanopore Technologies today announced that Rosemary Sinclair Dokos has been appointed as Chief Product and Marketing Officer and Dr Lakmal Jayasinghe has been appointed as Chief Scientific Officer, effective immediately. Rosemary and Lakmal succeed Clive Brown, Chief Officer of Technology, Innovation, and Products, who has stepped down to pursue new projects. Clive will be [...]

Re:Build Manufacturing Launches Ensorcell to Engineer and Manufacture Innovative and Affordable Life Science Tools

Framingham, MA – Ensorcell, the newest company to emerge from Re:Build Manufacturing, has officially launched operations in Framingham, Massachusetts. Ensorcell evaluates critical research and bioprocess technologies to develop innovative, intuitive and cost-effective solutions. Research, development and manufacturing are all United States-based, drawing from the vast network of cross-sector engineering and operations expertise in the Re:Build Manufacturing ecosystem. “At Re:Build [...]

MGI Tech Joins Forces with SAMRC and DSTI to Launch South Africa’s 110K Human Genome Program and Unveil Africa’s First DNBSEQ-T7, Ushering a New Era in African Genomics

CAPE TOWN, South Africa -- MGI Tech Co., Ltd., a company dedicated to developing core tools and technologies that drive innovation in life sciences, today announced two historic milestones in African genomics: the official unveiling of the continent's first DNBSEQ-T7 sequencing platform at the South African Medical Research Council (SAMRC), and the signing of a Memorandum [...]

mzio GmbH and Bright Giant GmbH Announce Seamless Integration Between mzmine and SIRIUS

mzio GmbH and Bright Giant GmbH announce a new integration between mzmine and SIRIUS. This collaboration enables researchers to launch SIRIUS analysis directly from mzmine feature tables, automating result handling and eliminating the need for manual data transfer to streamline small molecule discovery workflows. Bremen, Germany and Jena, Germany – mzio GmbH, the company behind the [...]

PreOmics Launches New Plasma Proteomics Solution P2-iST and Announces the Formation of Biognosys Group

PreOmics Launches New Plasma Proteomics Solution P2-iST and Announces the Formation of Biognosys Group • P2-iST Plasma Launch: The new nanoparticle-based plasma proteomics workflow combines Biognosys’ P2 Plasma Enrichment with PreOmics’ iST technology, achieving identification of nearly 6,000 plasma proteins with >90% data completeness, exceptional precision, and scalability up to 192 samples processed per day. [...]

SMi Systems Appoints Ronnie Andrews of Bethesda Group Advisors as Non-Executive Director

LONDON -- SMi Systems, a leading innovator in single-molecule detection for drug discovery and diagnostics, announces the appointment of Ron Andrews, Founder and Managing Partner of Bethesda Group Advisors, to its Board of Directors as a Non-Executive Director. During more than 35 years of strategic leadership in the Life Sciences Tools and Molecular Diagnostics sectors, Mr Andrews [...]

Avantor® Appoints Mary Blenn as Executive Vice President and Chief Operating Officer

RADNOR, Pa. -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies industries, today announced that Mary Blenn has been appointed to the newly created role of Executive Vice President and Chief Operating Officer, effective immediately. Ms. Blenn will report to President and CEO [...]

Revvity to Acquire ACD/Labs to Expand its Signals Software Capabilities

Acquisition deepens Revvity Signals’ presence in research informatics while furthering its ongoing expansion into development and manufacturing solutions WALTHAM, Mass. -- Revvity, Inc. (NYSE: RVTY), today announced it has entered into a definitive agreement to acquire ACD/Labs, a global provider of scientific software solutions that support analytical characterization and molecular design across pharmaceutical and material sciences end [...]

Revvity Collaborates with MDIC and NIST to Launch New Somatic Cancer Reference Standards to Monitor Diagnostic Assay Accuracy

WALTHAM, Mass. -- Revvity, Inc., today announced the launch of new highly-characterized somatic cancer reference standards developed in collaboration with the Medical Device Innovation Consortium (MDIC) and the National Institute of Standards and Technology (NIST) as part of the Somatic Reference Samples (SRS) Initiative. The Somatic Reference Samples (SRS) Initiative is a public-private partnership convened and [...]

Access IBO on Knowledge Center